Venture - Series Unknown Funded Startups in Denmark
Across the 20 most recent “Venture - Series Unknown” rounds in Denmark, the largest disclosed amount is NMD Pharma’s $120M (2022-02-15), which dwarfs most…
Across the 20 most recent “Venture - Series Unknown” rounds in Denmark, the largest disclosed amount is NMD Pharma’s $120M (2022-02-15), which dwarfs most other disclosed rounds here—NORNORM’s $59M (2025-10-02) and Ageras’s $36M (2022-08-11) are among the next-largest figures, while several others sit below $10M (e.g., Ocean.io $7M on 2022-01-14; Chromologics $8M on 2025-11-22). Undisclosed amounts also appear repeatedly (Legacy on 2025-10-30; COBOD International on 2022-07-25; Airtame on 2021-10-12), complicating comparisons.
Date-wise, the disclosed activity is concentrated in two waves: February 2022 (Cardlay $900K on 2022-03-09; plus NMD Pharma $40M and ViaBill $120M on 2022-02-15) and late 2022 (Rokoko $3M and CathVision $7M on 2022-08-17; Plytix $9M on 2022-09-09). Sector-wise, biotechnology shows up in 3+ entries (Chromologics $8M on 2025-11-22; Eupry $2M on 2022-08-08; NMD Pharma $40M on 2022-02-15; 21st.BIO $97M on 2021-12-21), with city concentration visible in Copenhagen-based entries across multiple years (e.g., NORNORM 2025-10-02; Ocean.io 2022-01-14). Rows span 2021-01-07 (Too Good To Go Denmark) through 2025-11-22 (Chromologics).
Most recent rounds
20 shownRelated listings
Frequently asked
Which disclosed round is the outlier, and how far above the rest does it sit?
NMD Pharma’s $120M round on 2022-02-15 is the largest disclosed amount in this list and is substantially higher than the next-largest disclosed figures, including NORNORM’s $59M on 2025-10-02 and Ageras’s $36M on 2022-08-11.
Are the largest values clustered around a particular period or do they appear across the full date range?
High disclosed amounts concentrate around February 2022 and late 2022: ViaBill’s $120M and NMD Pharma’s $40M both land on 2022-02-15, while multiple sizable rounds follow in August 2022 (Ageras $36M on 2022-08-11; CathVision $7M and Rokoko $3M on 2022-08-17). The table also includes later outliers like NORNORM $59M on 2025-10-02, but the densest run of major figures is in early/mid-2022.
Do any cities or metro areas recur strongly across these Denmark-based entries?
Copenhagen appears repeatedly, including NORNORM (2025-10-02), Ocean.io (2022-01-14), and Ageras (2022-08-11). Other locations show up less often, such as Odense for Cardlay ($900K on 2022-03-09) and Aarhus for ViaBill ($120M on 2022-02-15), indicating a Copenhagen-heavy geography within this slice.
What does the sector mix look like—are there categories over-represented in this set?
Biotechnology is the most clearly recurring sector, appearing in Chromologics ($8M on 2025-11-22), Eupry ($2M on 2022-08-08), NMD Pharma ($40M on 2022-02-15), and 21st.BIO ($97M on 2021-12-21). Several other sectors show up once or twice, such as Commerce and Shopping (NORNORM is Consumer Goods, but the list includes Commerce/Shopping entities like Ageras, Plytix, and ViaBill).
How should “undisclosed” amounts affect comparisons in this dataset?
Three entries in the displayed 20 rows list “undisclosed” amounts (Legacy on 2025-10-30; COBOD International on 2022-07-25; Airtame on 2021-10-12). Because the largest disclosed comparisons rely only on disclosed figures like NMD Pharma’s $120M (2022-02-15), the presence of undisclosed rounds means some of the true ranking order may be incomplete.
Which entries closed most recently in this view, and do they match the overall size pattern?
The two most recent rounds are Chromologics on 2025-11-22 ($8M) and Legacy on 2025-10-30 (undisclosed), followed by NORNORM on 2025-10-02 ($59M). The $59M figure is on the higher end relative to most other disclosed rounds in the table, while Chromologics’ $8M sits closer to the lower-disclosed cluster (e.g., Eupry $2M on 2022-08-08; Ocean.io $7M on 2022-01-14).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.